News
2mon
MyChesCo on MSNChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingSPRING HOUSE, PA and WATERTOWN, MA — ChromaTan Inc. and Landmark Bio PBLLC have been ... to support the development of an ...
The collaboration will leverage ChromaTan's BioRMB™ technology and Kascade instrumentation along with Landmark Bio's expertise in viral vector process development, chemistry, manufacturing and ...
Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for advanced ... medicine compatriot Landmark Bio. The financial terms of the ...
process development, and manufacturing of genetic medicines. The acquisition enables Landmark Bio to continue to deliver on its mission of translating groundbreaking research into life-changing ...
Landmark Bio, a cell and gene therapy manufacturing company, announced it has been acquired by Artis BioSolutions (Artis), a newly launched company dedicated to streamlining the discovery, process ...
As part of Artis, Landmark Bio will continue to operate as a distinct entity, providing critical services in translational research, process development, and manufacturing for clinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results